Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/2811?utm_source=openpr_ss
However, the side effects of migraine medications are expected to limit market growth. On the contrary, it is expected that new emerging therapies / medications for the treatment of migraine and growth opportunities in emerging countries present opportunities for market growth during the forecast period.
By type, abortifacient drugs accounted for more than three quarters of the global market for migraine drugs in 2017. In addition, by administration, the oral segment is expected to grow at the highest rate of 3.4% during the forecast period.
Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2811?utm_source=openpr_ss
Key Market Players:
• Abbott Laboratories
• Allergan Plc.
• Eisai Co. Ltd.
• Endo International Plc.
• GlaxoSmithKline Plc.
• Impax Laboratories
Key Findings of Migraine Drugs Market:
•North America occupied the two-fifths of the world market for migraine medicines.
•It is anticipated that Oral will grow with the highest CAGR throughout the forecast period.
•It is expected that Europe will occupy more than a quarter of the market share of the global market for migraine drugs by 2025.
•It is anticipated that Asia-Pacific will grow at the highest rate during the analysis period, followed by LAMEA.
Browse More Information of Report @ https://www.alliedmarketresearch.com/press-release/migraine-drugs-market.html
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025 here
News-ID: 1577855 • Views: 359
More Releases from Allied Market Research
Sodium Aluminum Silicate Market 2020 Along With Covid-19 Impact Analysis, Advanc …
Allied Market Research published a new report, titled Sodium Aluminum Silicate Market: Global Opportunity Analysis and Industry Forecast 2020–2027” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken
Siloxane Copolymer Lubricants Market Growing Popularity and Emerging Trends | Do …
Allied Market Research published a new report, titled Siloxane Copolymer Lubricants Market: Global Opportunity Analysis and Industry Forecast 2020–2027” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken
Immunoprotein Diagnostic Testing Market Industry Size, Share, Trends, Growth, To …
The global immunoprotein diagnostic testing market was pegged at $10.13 billion in 2019, and projected to reach $18.38 billion by 2027, growing at a CAGR of 6.6% from 2020 to 2027. Rise in incidence of chronic and infectious diseases and advancements in technologies have boosted the growth of the global immunoprotein diagnostic testing market Request Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/486 Rise in incidence of chronic and infectious diseases and advancements in technologies have
Disposable Medical Sensors Market is expected to reach at $9,700 million by 2023 …
The global disposable medical sensor market was valued at $4,823 million in 2016, and is projected to reach $9,700 million by 2023, growing at a CAGR of 10.2% from 2017 to 2023. The biosensor segment accounted for nearly three sevenths share of the total market in 2016. Request Sample Report at:https://www.alliedmarketresearch.com/request-sample/2299 Covid-19 Impact on the Global Disposable Medical Sensors Market: Global Disposable Medical Sensors Market Report provides an overview of the market based
More Releases for Migraine
EpiCast Report: Migraine-Epidemiology Forecast to 2026
Migraine is characterized by recurring headaches and throbbing pain on one side of the head accompanied by nausea, vomiting, or increased sensitivity to light or smell. While most migraineurs experience episodic migraines (EM), a small percentage suffers from chronic migraine (CM). In addition to its debilitating pain, migraines are also associated with more severe cardiovascular and neuropsychological comorbidities. Because migraine is one of the most prevalent types of headache, there
Migraine Therapeutics Pipeline Analysis -Results, Designation, Collaboration
Migraine is a type of a severe headache that is characterized by the intense throbbing in one area of the head. According to National Institute of Neurological Disorders and Stroke, migraine is three times common in women than in men and it is heralded by visual disturbances such as zig-zag lines vision and flashing lights. Access Report Overview: https://www.psmarketresearch.com/market-analysis/migraine-therapeutics-pipeline-analysis People having migraine generally have frequent attacks that cause, anxiety, stress,
Migraine KOL Interview
ReportsWorldwide has announced the addition of a new report title Migraine KOL Interview to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access February 08, 2017 We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic
Migraine Disease Coverage Forecast and Market Analysis
ReportsWorldwide has announced the addition of a new report title Migraine Disease Coverage Forecast and Market Analysis to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/migraine-disease-coverage-forecast-and-market-analysis Introduction Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.
Global Migraine Market: Industry Analysis & Outlook 2021
Migraine is a chronic neurovascular disorder characterized by severe recurrent headaches. It is one of the most common and most prevalent disabling neurological conditions, characterized by episodes often called migraine attacks. They are quite different from regular headaches which are non-migrainous. Migraineurs generally have a lower threshold to triggers that might cause neuronal hyperexcitability, including sleep disturbances, environmental or emotional challenges, alcohol exposure, diet, and hormonal cycles/changes, among others. Migraine
Increasing incidences of migraine sufferers driving the Anti-Migraine Drugs Mark …
Antimigraine drugs are the therapeutic agents indicated to use against migraine headaches. Migraine is characterized by recurrent attacks of moderate to severe headaches along with other nervous system symptoms. Migraine is more common in women than men, majorly due to the fluctuations in the harmone levels. According to a Medline article, around 12% of the U.S. population suffers from migraine headaches. The two major types of migraine are classic and